A novel animal model of Borrelia recurrentis Louse-Borne relapsing fever borreliosis using immunodeficient mice

PLoS Neglected Tropical Diseases

Volumn 3, Issue 9, 2009, Pages

  Larsson, Christer ^a   Lundqvist, Jenny ^a   Van Rooijen, Nico ^b   Bergström, Sven ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CLODRONIC ACID; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; BACTERIAL GROWTH; BAGG ALBINO MOUSE; BORRELIA; BORRELIA DUTTONII; BORRELIA INFECTION; BORRELIA RECURRENTIS; CONTROLLED STUDY; DISEASE SEVERITY; EXPERIMENTAL MOUSE; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; INFECTION CONTROL; LETHALITY; MACROPHAGE FUNCTION; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PERSISTENT INFECTION; PHAGOCYTE; SCID MOUSE; STRAIN DIFFERENCE; T CELL DEPLETION; WILD TYPE;

EID: 70449514690     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000522     Document Type: Article

References (37)

1. Bryceson AD, Parry EH, Perine PL, Warrell DA, Vukotich D, et al. (1970) Louse-borne relapsing fever. Q J Med 39: 129-170.
2. Felsenfeld O (1971) Borrelia: Strains, Vectors, Human and Animal Borreliosis. Green, St Louis, MO, 1971.
3. Ramos JM, Malmierca E, Reyes F, Tesfamariam A (2009) Louse-borne relapsing fever in Ethiopian children: experience of a rural hospital. Trop Doct 39: 34-36.
4. Abdalla RE (1969) Some studies on relapsing fever in the Sudan. J Trop Med Hyg 72: 125-128.
5. de Jong J, Wilkinson RJ, Schaeffers P, Sondorp HE, Davidson RN (1995) Louse-borne relapsing fever in southern Sudan. Trans R Soc Trop Med Hyg 89: 621. (Pubitemid 26016342)
6. Ramos JM, Malmierca E, Reyes F, Tesfamariam A (2008) Results of a 10-year survey of louse-borne relapsing fever in southern Ethiopia: a decline in endemicity. Ann Trop Med Parasitol 102: 467-469. (Pubitemid 352008728)
7. Cutler SJ (2006) Possibilities for relapsing fever reemergence. Emerg Infect Dis [serial on the Internet] Mar. Available at: http://www.cdc.gov/ ncidod/EID/vol12no03/05-0899.htm
8. Raoult D, Roux V (1999) The body louse as a vector of reemerging human diseases. Clin Infect Dis 29: 888-911. (Pubitemid 30256387)
9. Lescot M, Audic S, Robert C, Nguyen TT, Blanc G, et al. (2008) The genome of Borrelia recurrentis, the agent of deadly louse-borne relapsing fever, is a degraded subset of tick-borne Borrelia duttonii. PLoS Genet 4: e1000185. doi:10.1371/journal.pgen.1000185.
10. Judge DM, La Croix JT, Perine PL (1974) Experimental louse-borne relapsing fever in the grivet monkey, Cercopithecus aethiops. I. Clinical course. AmJ Trop Med Hyg 23: 957-961.
11. Cutler SJ, Fekade D, Hussein K, Knox KA, Melka A, et al. (1994) Successful invitro cultivation of Borrelia recurrentis. Lancet 343: 242. (Pubitemid 24031669)
12. Bosma GC, Custer RP, Bosma MJ (1983) A severe combined immunodeficiency mutation in the mouse. Nature 301: 527-530. (Pubitemid 13160576)
13. Flanagan SP (1966) 'Nude', a new hairless gene with pleiotropic effects in the mouse. Genet Res 8: 295-309.
14. Perou CM, Moore KJ, Nagle DL, Misumi DJ, Woolf EA, et al. (1996) Identification of the murine beige gene by YAC complementation and positional cloning. Nat Genet 13: 303-308.
15. Cote CK, Rea KM, Norris SL, van Rooijen N, Welkos SL (2004) The use of a model of in vivo macrophage depletion to study the role of macrophages during infection with Bacillus anthracis spores. Microb Pathog 37: 169-175.
16. Kaparakis M, Walduck AK, Price JD, Pedersen JS, van Rooijen N, et al. (2008) Macrophages are mediators of gastritis in acute Helicobacter pylori infection in C57BL/6 mice. Infect Immun 76: 2235-2239. (Pubitemid 351656160)
17. Samsom JN, Annema A, Groeneveld PH, van Rooijen N, Langermans JA, et al. (1997) Elimination of resident macrophages from the livers and spleens of immune mice impairs acquired resistance against a secondary Listeria monocytogenes infection. Infect Immun 65: 986-993. (Pubitemid 27088001)
18. Van Andel RA, Hook RR, Jr, Franklin CL, Besch-Williford CL, van Rooijen N, et al. (1997) Effects of neutrophil, natural killer cell, and macrophage depletion on murine Clostridium piliforme infection. Infect Immun 65: 2725-2731.
19. Van Rooijen N, Sanders A (1994) Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods 174: 83-93. (Pubitemid 24297139)
20. Buiting AM, Zhou F, Bakker JA, van Rooijen N, Huang L (1996) Biodistribution of clodronate and liposomes used in the liposome mediated macrophage 'suicide' approach. J Immunol Methods 192: 55-62.
21. Larsson C, Lundqvist J, Bergstrom S (2008) Residual brain infection in murine relapsing fever borreliosis can be successfully treated with ceftriaxone. Microb Pathog 44: 262-264.
22. Larsson C, Andersson M, Guo BP, Nordstrand A, Hagerstrand I, et al. (2006) Complications of pregnancy and transplacental transmission of relapsing-fever borreliosis. J Infect Dis 194: 1367-1374. (Pubitemid 44706504)
23. Barbour AG (1984) Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med 57: 521-525. (Pubitemid 15151039)
24. Larsson C, Andersson M, Pelkonen J, Guo BP, Nordstrand A, et al. (2006) Persistent brain infection and disease reactivation in relapsing fever borreliosis. Microbes Infect 8: 2213-2219. (Pubitemid 44311583)
25. Lopez JE, Schrumpf ME, Raffel SJ, Policastro PF, Porcella SF, et al. (2008) Relapsing fever spirochetes retain infectivity after prolonged in vitro cultivation. Vector Borne Zoonotic Dis 8: 813-820.
26. Malkiel S, Kuhlow CJ, Mena P, Benach JL (2009) The loss and gain of marginal zone and peritoneal B cells is different in response to relapsing fever and Lyme disease Borrelia. J Immunol 182: 498-506.
27. Connolly SE, Benach JL (2001) Cutting edge: the spirochetemia of murine relapsing fever is cleared by complement-independent bactericidal antibodies. J Immunol 167: 3029-3032.
28. Newman K, Jr, Johnson RC (1981) In vivo evidence that an intact lytic complement pathway is not essential for successful removal of circulating Borrelia turicatae from mouse blood. Infect Immun 31: 465-469.
29. McKisic MD, Barthold SW (2000) T-cell-independent responses to Borrelia burgdorferi are critical for protective immunity and resolution of lyme disease. Infect Immun 68: 5190-5197.
30. Londono D, Marques A, Hornung RL, Cadavid D (2008) IL-10 helps control pathogen load during high-level bacteremia. J Immunol 181: 2076-2083.
31. Meri T, Cutler SJ, Blom AM, Meri S, Jokiranta TS (2006) Relapsing fever spirochetes Borrelia recurrentis and B. duttonii acquire complement regulators C4b-binding protein and factor H. Infect Immun 74: 4157-4163. (Pubitemid 43993349)
32. Grosskinsky S, Schott M, Brenner C, Cutler SJ, Kraiczy P, et al. (2009) Borrelia recurrentis employs a novel multifunctional surface protein with anti-complement, anti-opsonic and invasive potential to escape innate immunity. PLoS ONE 4: e4858.
33. McCall PJ, Hume JC, Motshegwa K, Pignatelli P, Talbert A, et al. (2007) Does tick-borne relapsing fever have an animal reservoir in East Africa? Vector Borne Zoonotic Dis 7: 659-666.
34. Blanc G, Ogata H, Robert C, Audic S, Suhre K, et al. (2007) Reductive genome evolution from the mother of Rickettsia. PLoS Genet 3: e14. doi:10.1371/journal.pgen.0030014. (Pubitemid 46168837)
35. Davis PH, Stanley SL, Jr (2003) Breaking the species barrier: use of SCID mouse-human chimeras for the study of human infectious diseases. Cell Microbiol 5: 849-860.
36. Vidal V, Scragg IG, Cutler SJ, Rockett KA, Fekade D, et al. (1998) Variable major lipoprotein is a principal TNF-inducing factor of louse-borne relapsing fever. Nat Med 4: 1416-1420. (Pubitemid 28553465)
37. Battisti JM, Raffel SJ, Schwan TG (2008) A system for site-specific genetic manipulation of the relapsing fever spirochete Borrelia hermsii. Methods Mol Biol 431: 69-84.